Fermentalg WKN: A1103M ISIN: FR0011271600 Kürzel: 1F6 Branche: Chemie, Pharma, Biotechnologie
Marktkapitalisierung
24,0 Mio. EUR
KGV
-2,93
Ergebnis je Aktie
-0,20 EUR
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
k.A. % HL
Intervall: k.A.
High: k.A.
Low: k.A.
Börse: k.A.
Anzeige
S
Sergej555,
FERMENTALG
Hauptdiskussion, 10. Feb 11:43 Uhr
Ich hoffe 3€
E
Einfach_Ich,
FERMENTALG
Hauptdiskussion, 10. Feb 11:15 Uhr
Schon erstaunlich das sie nach dem Rücksetzer weiter steigt.
Vielleicht sehen wir bald 1 €.🤔
ElZorroBieroso,
FERMENTALG
Hauptdiskussion, 6. Feb 20:06 Uhr
The documents relating to the General Meeting provided to shareholders must be published on the Company's website, no longer twenty-one (21) days before the date of the General Meeting but only on the date of convocation.
The notice of availability of the preparatory documents for the general meeting will no longer be required.
The publication on the Company's website of the results of the votes and the minutes of the general meeting will no longer be required.
The Company will no longer be subject to the «say on pay» mechanism providing for the prior vote of shareholders on the executive remuneration policy, the subsequent vote on the remuneration report and the approval of individual executive remuneration.
The Corporation will no longer be held accountable for internal control or risk management.
The Company will no longer be subject to the provisions of Articles L. 823-19 and following of the French Commercial Code as regards audit committees, but may maintain this committee if it so wishes.
Indicative timetable for the transfer to Euronext Growth Paris
In the coming days, an application to delist the shares of Euronext Paris' Fermentalg and their concomitant admission to Euronext Growth Paris will be filed with Euronext Paris. Subject to the agreement of Euronext Paris, admission to Euronext Growth Paris will take place within a minimum period of two (2) months from the General Meeting that approved the Transfer, at the earliest on 2 April 2024, and within the limit of twelve (12) month following the date of the General Meeting.
The Company will be supported in its transfer project on Euronext Growth Paris by CIC Market Solutions as a listing sponsor.
Next publication: results of the 2023 financial year and
turnover of the 1st quarter 2024, 3 April 2024 (after the closing of the markets)
ElZorroBieroso,
FERMENTALG
Hauptdiskussion, 6. Feb 20:05 Uhr
In terms of periodic information:
The half-yearly report, including the half-yearly (and consolidated) financial statements and an activity report relating to these half-yearly financial statements, will be published within four months of the end of the first half of the Company's financial year, instead of the three-month period applicable to companies whose securities are admitted to trading on a regulated market.
The statutory auditors' review of the half-year accounts will be maintained, although no longer required.
Some information required under the management and corporate governance report will be reduced.
The Company will continue to prepare consolidated financial statements in accordance with IFRS accounting standards.
The Company will continue with the current publication of its quarterly financial information.
For ongoing information:
Euronext Growth Paris being a multilateral trading system, the Company would remain subject to the provisions applicable to permanent market information, and in particular to the provisions of the Regulation (EU) n°596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (" MAR"). Any company listed on Euronext Growth Paris must ensure the effective and complete dissemination of the so-called regulated information.
In addition, the officers of the Company and persons closely associated with them would remain subject to the obligation to report transactions in the Company's shares or debt instruments in accordance with section 19 of the MAR Regulation.
As regards the protection of minority shareholders:
Unless otherwise agreed, the protection of minority shareholders is ensured on Euronext Growth Paris by the mandatory public offer mechanism in the event of crossing, directly or indirectly, alone or in concert, the 50% threshold of the capital or voting rights.
Only crossings, up or down, of thresholds of 50% and 95% of the capital or voting rights are to be reported to the AMF and the Company, subject to crossings of statutory thresholds to be reported to the Company.
ElZorroBieroso,
FERMENTALG
Hauptdiskussion, 6. Feb 20:05 Uhr
Subject to the agreement of Euronext Paris, the listing of the company on Euronext Growth Paris will be carried out as part of an accelerated procedure for the admission to trading of the company's existing shares, without issuing new shares.
Reasons for the transfer
This project aims to enable the company Fermentalg S.A. to reduce the constraints associated with the regulated market Euronext Paris and the resources committed to meet them. Euronext Growth Paris offers a simplified operation, more adapted to the size, activity, market capitalization and needs of the Company, while allowing it to continue to benefit from the attractiveness of the financial markets.
Consequences of the transfer
In accordance with current regulations, the Company wishes to inform its shareholders of certain possible consequences of such a Transfer (non-exhaustive list):
ElZorroBieroso,
FERMENTALG
Hauptdiskussion, 6. Feb 20:05 Uhr
Heute im Newsletter
Libourne – February 6, 2024 – The General Assembly of Fermentalg (FALG), meeting on February 2, 2024, approved in accordance with the provisions of Article L.421-14 of the French Monetary and Financial Code, the proposed listing transfer of its securities on the regulated market Euronext Paris (Subfund C), to Euronext Growth Paris, and conferred all powers to the Board of Directors to implement this listing market transfer. The Board of Directors, which met on 5 February 2024, decided to implement this transfer.
D
Dr.Future,
FERMENTALG
Hauptdiskussion, 5. Feb 20:10 Uhr
240% in einem Monat
D
Dr.Future,
FERMENTALG
Hauptdiskussion, 5. Feb 20:10 Uhr
Wow was geht hier ab 🗽🗽🗽
S
Sergej555,
FERMENTALG
Hauptdiskussion, 5. Feb 9:51 Uhr
Super!
S
Sergej555,
FERMENTALG
Hauptdiskussion, 3. Feb 11:27 Uhr
Bin dabei, EK 0,55 Euro
ElZorroBieroso,
FERMENTALG
Hauptdiskussion, 2. Feb 12:58 Uhr
Die Zahlen sind allerdings mega.
https://www.finanznachrichten.de/nachrichten-2024-01/61237570-fermentalg-after-eur4m-in-sales-in-2023-fermentalg-kicks-off-2024-with-over-eur9m-in-contracts-and-orders-650.htm
90 Prozent des Ziels für 2024 schon erfüllt. Ich lege nochmal nach beim nächsten kleinen Dip Richtung 0,39.
ElZorroBieroso,
FERMENTALG
Hauptdiskussion, 2. Feb 8:44 Uhr
Puuh noch schnell nachlegen?
E
Einfach_Ich,
FERMENTALG
Hauptdiskussion, 31. Jan 15:59 Uhr
Läuft alles merkwürdig bei diesem Wert, wenn jetzt noch eine Empfehlung kommt wer weiß.
E
Einfach_Ich,
FERMENTALG
Hauptdiskussion, 29. Jan 19:50 Uhr
Letzte Woche gab es etwas siehe Post vorher.
Aber warum es heute steigt gute Frage.
Unleashed,
FERMENTALG
Hauptdiskussion, 29. Jan 16:45 Uhr
Ja aber gibt es Informationen weshalb es steigt?
|
Themen zum Wert | ||
---|---|---|---|
1 | FERMENTALG Hauptdiskussion |
Kursdetails
Geld (bid) | 0,5930 (1.626) |
---|---|
Brief (ask/offer) | 0,5960 (1.626) |
Spread | 0,5034 |
Geh. Stück | 0 |
Eröffnung | 0,5995 |
Vortag | 0,5995 |
Tageshoch | 0,6120 |
Tagestief | 0,5860 |
52W Hoch | 1,0360 |
52W Tief | 0,2068 |
Tagesvolumen
in EUR gehandelt | 157 Tsd. Stk |
---|---|
Gesamt | 157 Tsd. Stk |
Partner-News
Anzeige16:46 Uhr • Partner • Societe Generale
15:42 Uhr • Partner • Societe Generale
15:10 Uhr • Partner • onemarkets Blog
15:00 Uhr • Partner • BNP Paribas
13:31 Uhr • Partner • Societe Generale
Aktien-News
17:09 Uhr • Artikel • dpa-AFX
17:09 Uhr • Meldungen • EQS News
17:05 Uhr • Meldungen • EQS News
17:00 Uhr • Meldungen • EQS News
16:54 Uhr • Meldungen • EQS News
Geld/Brief Kurse
Neu ladenBörse | Geld | Vol. | Brief | Vol. | Zeit | Vol. ges. | Kurs |
---|---|---|---|---|---|---|---|
L&S Exchange | 0,5930 | 1.626 Stk | 0,5960 | 1.626 Stk | 1713540015 17:20 | 945 Stk | 0,5945 EUR |
Baader Bank | 0,5830 | 2.941 Stk | 0,6070 | 2.944 Stk | 1713539565 17:12 | 0,5945 EUR | |
Euronext Paris | 0,5920 | 0,5850 | 1713454514 18. Apr | 153 Tsd. Stk | 0,6020 EUR | ||
Frankfurt | 0,5820 | 3.000 Stk | 0,6070 | 3.000 Stk | 1713506734 08:05 | 0,5780 EUR | |
Tradegate | 0,5930 | 1.860 Stk | 0,5970 | 1.850 Stk | 1713472008 18. Apr | 1.201 Stk | 0,6000 EUR |
Lang & Schwarz | 0,5930 | 1.626 Stk | 0,5960 | 1.626 Stk | 1713540015 17:20 | 0,5945 EUR | |
London | 1713510320 09:05 | 2 Stk | 0,6160 EUR | ||||
Berlin | 0,5820 | 3.000 Stk | 0,6080 | 3.000 Stk | 1713507309 08:15 | 0,5800 EUR | |
München | 0,5820 | 3.000 Stk | 0,6070 | 3.000 Stk | 1713507294 08:14 | 0,5800 EUR | |
Stuttgart | 0,5800 | 5.000 Stk | 0,6090 | 5.000 Stk | 1713537497 16:38 | 0,5780 EUR | |
Gettex | 0,5830 | 2.941 Stk | 0,6070 | 2.941 Stk | 1713539629 17:13 | 1.163 Stk | 0,5900 EUR | ges. 156.670 Stk |
Realtime / Verzögert
Börsennotierung
Marktkapitalisierung in EUR |
---|
24,0 Mio. |
Anzahl der Aktien |
41,3 Mio. |
Termine
04.07.2024 | Quartalsmitteilung |
---|---|
11.09.2024 | Quartalsmitteilung |
03.10.2024 | Quartalsmitteilung |
01/25 | Quartalsmitteilung |
Aktionärsstruktur %
Freefloat | 0,00 |
0,00 |
Grundlegende Daten zur FERMENTALG Aktie
Finanzdaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
---|---|---|---|---|---|---|---|
KUV | - | 21,54 | 8,49 | 3,03 | - | - | - |
Ergebnis je Aktie (bereinigt) | -0,27 | -0,17 | -0,24 | -0,33 | -0,20 | - | - |
Cashflow | -8,6 Mio. | -7,7 Mio. | -8,2 Mio. | -8,7 Mio. | - | - | - |
Eigenkapitalquote | 48,47 % | 77,21 % | 72,96 % | 61,39 % | - | - | - |
Verschuldungsgrad | 106,29 | 29,52 | 37,07 | 62,89 | - | - | - |
EBIT | -7,5 Mio. | -9,6 Mio. | -10,3 Mio. | -11,1 Mio. | - | - | - |
Fundamentaldaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
KCV | - | -15,87 | -7,64 | -1,44 | - | - | - |
Kurs-Gewinn-Verhältnis (KGV) | - | -17,74 | -6,37 | -0,92 | -2,93 | - | - |
Bilanzdaten | 2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e |
Umsatzerlöse | 2,2 Mio. | 5,6 Mio. | 7,6 Mio. | 4,1 Mio. | - | - | - |
Ergebnis vor Steuern | -8,2 Mio. | -7,9 Mio. | -10,7 Mio. | -13,3 Mio. | - | - | - |
Steuern | -1,3 Mio. | -1,0 Mio. | -0,9 Mio. | 875 Tsd. | - | - | - |
Ausschüttungssumme | - | - | 5,4 Mio. | - | - | - | - |